LifeMD
LFMD
84 hedge funds and large institutions have $106M invested in LifeMD in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 25 increasing their positions, 13 reducing their positions, and 11 closing their positions.
209% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 11
101% more call options, than puts
Call options by funds: $2.29M | Put options by funds: $1.14M
92% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 13
91% more capital invested
Capital invested by funds: $55.5M → $106M (+$50.6M)
35% more funds holding
Funds holding: 62 → 84 (+22)
8% more ownership
Funds ownership: 24.63% → 32.63% (+8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$6.12M |
| 2 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$4.62M |
| 3 |
Morgan Stanley
New York
|
+$3.91M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$2.38M |
| 5 |
LCM
Laurion Capital Management
New York
|
+$2.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
-$1.9M |
| 2 |
Millennium Management
New York
|
-$1.89M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.08M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$767K |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$525K |
LFMD Hedge Fund Activity: Q4 2023 in Review
84 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in LifeMD (LFMD) for Q4 2023, worth a combined $106M — up 91% from $55.5M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new LFMD positions and 11 closed out — a net gain of 23 holders — while 25 added to existing stakes and 13 trimmed.
The largest buyer was Invesco, opening a new position worth an estimated $6.12M. The largest seller was Royce & Associates, cutting an estimated $1.9M.
- 84 institutional investors held LifeMD (LFMD) as of Q4 2023, up from 62 in Q3 2023.
- Funds reported $106M of LifeMD stock for Q4 2023, up 91% quarter-over-quarter.
- 34 funds opened new LifeMD positions in Q4 2023 and 11 closed out, a net change of +23 holders.
- The largest LifeMD buyer in Q4 2023 was Invesco, an estimated $6.12M added.
- The largest LifeMD seller in Q4 2023 was Royce & Associates, an estimated $1.9M sold.
Based on aggregated 13F filings for Q4 2023.